• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021

    11/30/21 10:03:20 AM ET
    $ABEO
    $ACHR
    $AES
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Aerospace
    Industrials
    Get the next $ABEO alert in real time by email

     

    Upgrades

    • Sidoti & Co. upgraded the previous rating for DMC Global Inc (NASDAQ:BOOM) from Neutral to Buy. In the third quarter, DMC Glb showed an EPS of $0.02, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $70.00 and a 52-week-low of $35.50. At the end of the last trading period, DMC Glb closed at $37.04.
    • For MAG Silver Corp (AMEX:MAG), TD Securities upgraded the previous rating of Hold to Buy. MAG Silver earned $0.02 in the third quarter, compared to $0.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.43 and a 52-week-low of $14.15. MAG Silver closed at $16.35 at the end of the last trading period.
    • Daiwa Capital upgraded the previous rating for Zoom Video Communications Inc (NASDAQ:ZM) from Sell to Underperform. In the third quarter, Zoom Video Communications showed an EPS of $1.11, compared to $0.99 from the year-ago quarter. At the moment, the stock has a 52-week-high of $486.83 and a 52-week-low of $195.80. Zoom Video Communications closed at $218.98 at the end of the last trading period.
    • For Square Inc (NYSE:SQ), B of A Securities upgraded the previous rating of Underperform to Neutral. In the third quarter, Square showed an EPS of $0.37, compared to $0.34 from the year-ago quarter. The current stock performance of Square shows a 52-week-high of $289.23 and a 52-week-low of $191.36. Moreover, at the end of the last trading period, the closing price was at $212.87.
    • Jefferies upgraded the previous rating for Ayala Pharmaceuticals Inc (NASDAQ:AYLA) from Hold to Buy. In the third quarter, Ayala Pharmaceuticals showed an EPS of $0.68, compared to $0.59 from the year-ago quarter. At the moment, the stock has a 52-week-high of $28.68 and a 52-week-low of $7.74. Ayala Pharmaceuticals closed at $9.48 at the end of the last trading period.
    • For PetroChina Co Ltd (NYSE:PTR), JP Morgan upgraded the previous rating of Underweight to Overweight. In the third quarter, PetroChina Co showed an EPS of $1.87, compared to $0.03 from the year-ago quarter. The current stock performance of PetroChina Co shows a 52-week-high of $54.50 and a 52-week-low of $29.90. Moreover, at the end of the last trading period, the closing price was at $43.68.

    See all analyst ratings upgrades.

     

    Downgrades

    • Roth Capital downgraded the previous rating for Goodrich Petroleum Corp (AMEX:GDP) from Buy to Neutral. In the third quarter, Goodrich Petroleum showed an EPS of $1.10, compared to $0.18 from the year-ago quarter. The current stock performance of Goodrich Petroleum shows a 52-week-high of $26.66 and a 52-week-low of $8.61. Moreover, at the end of the last trading period, the closing price was at $23.00.
    • Argus Research downgraded the previous rating for Central Garden & Pet Co (NASDAQ:CENT) from Buy to Hold. Central Garden & Pet earned $0.06 in the fourth quarter, compared to $0.25 in the year-ago quarter. The current stock performance of Central Garden & Pet shows a 52-week-high of $62.91 and a 52-week-low of $36.53. Moreover, at the end of the last trading period, the closing price was at $49.55.
    • Barclays downgraded the previous rating for Cheniere Energy Partners LP (AMEX:CQP) from Equal-Weight to Underweight. In the third quarter, Cheniere Energy Partners showed an EPS of $0.69, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $45.75 and a 52-week-low of $32.73. At the end of the last trading period, Cheniere Energy Partners closed at $43.09.
    • According to SVB Leerink, the prior rating for Abeona Therapeutics Inc (NASDAQ:ABEO) was changed from Outperform to Market Perform. Abeona Therapeutics earned $0.16 in the third quarter, compared to $0.08 in the year-ago quarter. The stock has a 52-week-high of $3.79 and a 52-week-low of $0.64. At the end of the last trading period, Abeona Therapeutics closed at $0.65.
    • For SolarEdge Technologies Inc (NASDAQ:SEDG), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. In the third quarter, SolarEdge Technologies showed an EPS of $1.45, compared to $1.21 from the year-ago quarter. The current stock performance of SolarEdge Technologies shows a 52-week-high of $389.71 and a 52-week-low of $199.33. Moreover, at the end of the last trading period, the closing price was at $347.21.
    • Goldman Sachs downgraded the previous rating for Dollar Tree Inc (NASDAQ:DLTR) from Buy to Neutral. Dollar Tree earned $0.96 in the third quarter, compared to $1.39 in the year-ago quarter. At the moment, the stock has a 52-week-high of $149.37 and a 52-week-low of $84.26. Dollar Tree closed at $141.35 at the end of the last trading period.

    See all analyst ratings downgrades.

     

    Initiations

    • With a Buy rating, Maxim Group initiated coverage on ATAI Life Sciences NV (NASDAQ:ATAI). The price target seems to have been set at $25.00 for ATAI Life Sciences. The current stock performance of ATAI Life Sciences shows a 52-week-high of $22.91 and a 52-week-low of $10.45. Moreover, at the end of the last trading period, the closing price was at $10.99.
    • Maxim Group initiated coverage on Citius Pharmaceuticals Inc (NASDAQ:CTXR) with a Buy rating. The price target for Citius Pharmaceuticals is set to $4.00. For the third quarter, Citius Pharmaceuticals had an EPS of $0.05, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $4.56 and a 52-week-low of $0.93. At the end of the last trading period, Citius Pharmaceuticals closed at $1.62.
    • With a Neutral rating, B of A Securities initiated coverage on Spire Global Inc (NYSE:SPIR). The price target seems to have been set at $5.05 for Spire Globall. The stock has a 52-week-high of $19.50 and a 52-week-low of $4.46. At the end of the last trading period, Spire Globall closed at $4.49.
    • B of A Securities initiated coverage on Cian PLC (NYSE:CIAN) with a Neutral rating. The price target for Cian is set to $17.50.
    • With an Overweight rating, Morgan Stanley initiated coverage on IO Biotech Inc (NASDAQ:IOBT). The price target seems to have been set at $21.00 for IO Biotech.
    • Canaccord Genuity initiated coverage on ESS Tech Inc (NYSE:GWH) with a Buy rating. The price target for ESS Tech is set to $18.50.
    • Truist Securities initiated coverage on The Real Good Food Company Inc (NASDAQ:RGF) with a Buy rating. The price target for The Real Good Food is set to $15.00.
    • JMP Securities initiated coverage on Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) with a Market Outperform rating. The price target for Crinetics Pharmaceuticals is set to $43.00. In the third quarter, Crinetics Pharmaceuticals showed an EPS of $0.73, compared to $0.56 from the year-ago quarter. At the moment, the stock has a 52-week-high of $28.78 and a 52-week-low of $12.60. Crinetics Pharmaceuticals closed at $23.90 at the end of the last trading period.
    • HSBC initiated coverage on Beyond Meat Inc (NASDAQ:BYND) with a Reduce rating. The price target for Beyond Meat is set to $62.00. For the third quarter, Beyond Meat had an EPS of $0.87, compared to year-ago quarter EPS of $0.28. The current stock performance of Beyond Meat shows a 52-week-high of $221.00 and a 52-week-low of $72.51. Moreover, at the end of the last trading period, the closing price was at $74.60.
    • With an Outperform rating, Wedbush initiated coverage on Consensus Cloud Solutions Inc (NASDAQ:CCSI). The price target seems to have been set at $75.00 for Consensus Cloud Solutions.
    • HC Wainwright & Co. initiated coverage on Imara Inc (NASDAQ:IMRA) with a Buy rating. The price target for Imara is set to $10.00. Imara earned $0.55 in the third quarter, compared to $0.72 in the year-ago quarter. The stock has a 52-week-high of $29.91 and a 52-week-low of $3.05. At the end of the last trading period, Imara closed at $3.09.
    • With an Outperform rating, Wedbush initiated coverage on Ziff Davis Inc (NASDAQ:ZD). The price target seems to have been set at $150.00 for Ziff Davis. For the third quarter, Ziff Davis had an EPS of $2.34, compared to year-ago quarter EPS of $2.02.
    • Deutsche Bank initiated coverage on SmartRent Inc (NYSE:SMRT) with a Buy rating. The price target for SmartRent is set to $16.00.
    • With a Buy rating, Benchmark initiated coverage on PetIQ Inc (NASDAQ:PETQ). The price target seems to have been set at $30.00 for PetIQ. PetIQ earned $0.08 in the third quarter, compared to $0.11 in the year-ago quarter. At the moment, the stock has a 52-week-high of $46.00 and a 52-week-low of $20.51. PetIQ closed at $20.79 at the end of the last trading period.
    • With a Buy rating, Ladenburg Thalmann initiated coverage on Power & Digital Infrastructure Acquisition Corp (NASDAQ:XPDI). The price target seems to have been set at $18.75 for Power & Digital. The current stock performance of Power & Digital shows a 52-week-high of $14.98 and a 52-week-low of $9.72. Moreover, at the end of the last trading period, the closing price was at $13.04.
    • B of A Securities initiated coverage on Rocket Lab USA Inc (NASDAQ:RKLB) with a Buy rating. The price target for Rocket Lab USA is set to $20.00.
    • With an Overweight rating, Barclays initiated coverage on Surgery Partners Inc (NASDAQ:SGRY). The price target seems to have been set at $73.00 for Surgery Partners. For the third quarter, Surgery Partners had an EPS of $0.05, compared to year-ago quarter EPS of $0.53. The stock has a 52-week-high of $69.58 and a 52-week-low of $24.20. At the end of the last trading period, Surgery Partners closed at $45.48.
    • Barclays initiated coverage on DocGo Inc (NASDAQ:DCGO) with an Overweight rating. The price target for DocGo is set to $14.00.
    • With an Overweight rating, Barclays initiated coverage on Arhaus Inc (NASDAQ:ARHS). The price target seems to have been set at $18.00 for Arhaus.
    • With a Buy rating, Benchmark initiated coverage on Sports Entertainment Acquisition Corp (NYSE:SEAH). The price target seems to have been set at $16.00 for Sports Entertainment. The stock has a 52-week-high of $12.48 and a 52-week-low of $9.59. At the end of the last trading period, Sports Entertainment closed at $10.97.
    • HC Wainwright & Co. initiated coverage on Annexon Inc (NASDAQ:ANNX) with a Buy rating. The price target for Annexon is set to $40.00. For the third quarter, Annexon had an EPS of $0.93, compared to year-ago quarter EPS of $0.77. The current stock performance of Annexon shows a 52-week-high of $38.01 and a 52-week-low of $13.03. Moreover, at the end of the last trading period, the closing price was at $14.15.
    • DA Davidson initiated coverage on Trebia Acquisition Corp (NYSE:TREB) with a Buy rating. The price target for Trebia Acquisition is set to $23.00. The current stock performance of Trebia Acquisition shows a 52-week-high of $11.99 and a 52-week-low of $9.72. Moreover, at the end of the last trading period, the closing price was at $9.94.
    • With a Buy rating, Loop Capital initiated coverage on Shift4 Payments Inc (NYSE:FOUR). The price target seems to have been set at $69.00 for Shift4 Payments. In the third quarter, Shift4 Payments showed an EPS of $0.26, compared to $0.09 from the year-ago quarter. The current stock performance of Shift4 Payments shows a 52-week-high of $104.11 and a 52-week-low of $50.75. Moreover, at the end of the last trading period, the closing price was at $51.80.
    • Keefe, Bruyette & Woods initiated coverage on SoFi Technologies Inc (NASDAQ:SOFI) with a Market Perform rating. The price target for SoFi Technologies is set to $21.00. For the third quarter, SoFi Technologies had an EPS of $0.05, compared to year-ago quarter EPS of $0.70. At the moment, the stock has a 52-week-high of $24.95 and a 52-week-low of $13.56. SoFi Technologies closed at $18.43 at the end of the last trading period.
    • Goldman Sachs initiated coverage on The AES Corp (NYSE:AES) with a Buy rating. The price target for AES is set to $30.00. AES earned $0.50 in the third quarter, compared to $0.42 in the year-ago quarter. At the moment, the stock has a 52-week-high of $29.07 and a 52-week-low of $20.27. AES closed at $23.62 at the end of the last trading period.
    • Wedbush initiated coverage on Redbox Entertainment Inc (NASDAQ:RDBX) with an Outperform rating. The price target for Redbox Entertainment is set to $15.00.
    • Goldman Sachs initiated coverage on Fluence Energy Inc (NASDAQ:FLNC) with a Buy rating. The price target for Fluence Energy is set to $52.00.

    See all analyst ratings initiations.

    Get the next $ABEO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABEO
    $ACHR
    $AES
    $ANNX

    CompanyDatePrice TargetRatingAnalyst
    Shift4 Payments Inc.
    $FOUR
    4/22/2026$50.00Market Perform
    BMO Capital Markets
    Shift4 Payments Inc.
    $FOUR
    4/17/2026$50.00Overweight → Equal-Weight
    Stephens
    Fluence Energy Inc.
    $FLNC
    4/17/2026$8.00Neutral → Sell
    UBS
    Shift4 Payments Inc.
    $FOUR
    4/16/2026Buy → Neutral
    Seaport Research Partners
    SoFi Technologies Inc.
    $SOFI
    4/15/2026Hold
    Argus
    SolarEdge Technologies Inc.
    $SEDG
    4/15/2026$31.00Neutral → Sell
    Goldman
    Shift4 Payments Inc.
    $FOUR
    4/15/2026Outperform → Peer Perform
    Wolfe Research
    The AES Corporation
    $AES
    4/9/2026$15.00Positive → Neutral
    Susquehanna
    More analyst ratings

    $ABEO
    $ACHR
    $AES
    $ANNX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABEO
    $ACHR
    $AES
    $ANNX
    SEC Filings

    View All

    Citius Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer)

    4/24/26 5:00:16 PM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Consensus Cloud Solutions Inc.

    DEFA14A - Consensus Cloud Solutions, Inc. (0001866633) (Filer)

    4/24/26 4:31:55 PM ET
    $CCSI
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEF 14A filed by Consensus Cloud Solutions Inc.

    DEF 14A - Consensus Cloud Solutions, Inc. (0001866633) (Filer)

    4/24/26 4:31:00 PM ET
    $CCSI
    Computer Software: Prepackaged Software
    Technology

    $ABEO
    $ACHR
    $AES
    $ANNX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Shift4 Payments with a new price target

    BMO Capital Markets initiated coverage of Shift4 Payments with a rating of Market Perform and set a new price target of $50.00

    4/22/26 7:58:13 AM ET
    $FOUR
    Real Estate

    Shift4 Payments downgraded by Stephens with a new price target

    Stephens downgraded Shift4 Payments from Overweight to Equal-Weight and set a new price target of $50.00

    4/17/26 8:40:34 AM ET
    $FOUR
    Real Estate

    Fluence downgraded by UBS with a new price target

    UBS downgraded Fluence from Neutral to Sell and set a new price target of $8.00

    4/17/26 8:08:09 AM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    $ABEO
    $ACHR
    $AES
    $ANNX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Noto Anthony bought $500,516 worth of shares (28,900 units at $17.32), increasing direct ownership by 0.25% to 11,704,352 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/17/26 4:05:47 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Director Bohjalian Thomas N bought $260,490 worth of shares (150,000 units at $1.74), increasing direct ownership by 43% to 500,000 units (SEC Form 4)

    4 - SmartRent, Inc. (0001837014) (Issuer)

    3/12/26 6:25:23 PM ET
    $SMRT
    EDP Services
    Technology

    Director Carson William H. bought $45,360 worth of shares (8,000 units at $5.67), increasing direct ownership by 15% to 62,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    3/12/26 4:31:34 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEO
    $ACHR
    $AES
    $ANNX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Operating Officer Bansi Pankaj

    4 - SmartRent, Inc. (0001837014) (Issuer)

    4/24/26 7:02:14 PM ET
    $SMRT
    EDP Services
    Technology

    EVP & Chief HR Officer Mendoza Tish was granted 46,552 shares, increasing direct ownership by 16% to 334,972 units (SEC Form 4)

    4 - AES CORP (0000874761) (Issuer)

    4/24/26 4:18:50 PM ET
    $AES
    Electric Utilities: Central
    Utilities

    EVP, GC and Corp. Secretary Freedman Paul L was granted 44,483 shares, increasing direct ownership by 25% to 223,154 units (SEC Form 4)

    4 - AES CORP (0000874761) (Issuer)

    4/24/26 4:17:06 PM ET
    $AES
    Electric Utilities: Central
    Utilities

    $ABEO
    $ACHR
    $AES
    $ANNX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules

    CRANFORD, N.J., April 24, 2026 /PRNewswire/ -- Citius Pharmaceuticals Inc. (NASDAQ:CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase of an aggregate of 5,076,143 shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $0.985 per share (or pre-funded warrant in lieu thereof). In a concurrent private placement, the Company issued unregistered warrants to purchase up to 5,076,143 shares of common stock at an exe

    4/24/26 4:30:00 PM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Buy Research Opinion on Zoom Communications (NASDAQ: ZM)

    NOTE TO EDITORS: The Following Is an Investment Opinion Issued by Spruce Point Capital Management Provides Evidence the Bear Thesis on Zoom Shares Does Not Hold Up to Scrutiny Believes Zoom's Transformation Into a Comprehensive, Value-Added, AI-First Platform Poised to Drive Deeper Enterprise Penetration is Underappreciated Demonstrates Zoom is Trading at a Massive Discount to Its Intrinsic Value, Particularly Considering Its Share Ownership in AI Leader Anthropic Identifies A Range of Cost Structure, Organizational Effectiveness, Capital Allocation Practices, and Corporate Governance Concerns For Zoom to Address Announces It Has Sent the Zoom Board of Directors a Letter Containin

    4/24/26 8:30:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules

    CRANFORD, N.J., April 24, 2026 /PRNewswire/ -- Citius Pharmaceuticals Inc. (NASDAQ:CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into a definitive agreement for the purchase of an aggregate of 5,076,143 shares of its common stock  (or pre-funded warrants in lieu thereof) at a purchase price of $0.985 per share (or pre-funded warrant in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company will issue unregistered warrants to purchase up to 5,076,143 shares of comm

    4/24/26 8:00:00 AM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEO
    $ACHR
    $AES
    $ANNX
    Leadership Updates

    Live Leadership Updates

    View All

    Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer

    Ms. Deardorf is an experienced biopharma leader who will lead business development and corporate and commercial strategy as Neutrolis advances NTR-1011 into autoimmune diseases following positive Phase 1a results CAMBRIDGE, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- Neutrolis Inc. a clinical-stage biotechnology company focused on targeting Neutrophil Extracellular Traps (NETs) for the treatment of autoimmune and inflammatory diseases, today announced the appointment of Caren Deardorf as Chief Business & Strategy Officer (CBSO). Ms. Deardorf will lead corporate and pipeline strategy, business development, and early commercial strategy as the company advances its clinical pipeline. Ms. Dear

    4/15/26 2:00:00 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Zoom appoints Russell Dicker as chief product officer to advance AI-first product strategy and workflow automation

    SAN JOSE, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Zoom Communications, Inc. (NASDAQ:ZM) today announced the appointment of Russell Dicker as the company's chief product officer (CPO), leading product strategy for Zoom's system of action, turning conversations into completed work through AI. Russell brings more than 25 years of experience building and scaling global product platforms, including leading Microsoft Teams' product and data science teams, with a focus on applying AI to simplify workflows and improve how work gets done. Russell joins Zoom at a pivotal time, as companies seek AI tools to automate processes and tasks, freeing up time for higher-level work. Zoom is uniquely posi

    4/15/26 9:05:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    SoFi, Kelsea Ballerini, and CMA Launch Amplify Your Ambitions Contest to Empower America's Next Generation of Emerging Artists

    Emerging artists can win up to $200,000 and take the stage at an exclusive CMA Fest concert, as SoFi helps turn ambitions into financial realities SoFi, the one-stop shop for digital financial services, is launching the "Amplify Your Ambitions" Contest, a nationwide search to discover emerging artists as they pursue their ambitions and advance their careers, in partnership with the Country Music Association (CMA) and multi-platinum songwriter, producer, and author Kelsea Ballerini, a five-time GRAMMY® Award nominee and multiple ACM and CMA Award winner. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414427860/en/SoFi Amplif

    4/15/26 9:00:00 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $ABEO
    $ACHR
    $AES
    $ANNX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Caribou Biosciences Inc.

    SC 13D/A - Caribou Biosciences, Inc. (0001619856) (Subject)

    12/6/24 4:06:56 PM ET
    $CRBU
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/5/24 9:49:25 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/3/24 9:39:57 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $ABEO
    $ACHR
    $AES
    $ANNX
    Financials

    Live finance-specific insights

    View All

    Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Buy Research Opinion on Zoom Communications (NASDAQ: ZM)

    NOTE TO EDITORS: The Following Is an Investment Opinion Issued by Spruce Point Capital Management Provides Evidence the Bear Thesis on Zoom Shares Does Not Hold Up to Scrutiny Believes Zoom's Transformation Into a Comprehensive, Value-Added, AI-First Platform Poised to Drive Deeper Enterprise Penetration is Underappreciated Demonstrates Zoom is Trading at a Massive Discount to Its Intrinsic Value, Particularly Considering Its Share Ownership in AI Leader Anthropic Identifies A Range of Cost Structure, Organizational Effectiveness, Capital Allocation Practices, and Corporate Governance Concerns For Zoom to Address Announces It Has Sent the Zoom Board of Directors a Letter Containin

    4/24/26 8:30:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    DMC Global Schedules First Quarter Earnings Release and Conference Call

    BROOMFIELD, Colo., April 24, 2026 (GLOBE NEWSWIRE) -- DMC Global Inc. (NASDAQ:BOOM) will announce its 2026 first quarter financial results after the stock market closes on Thursday, April 30, 2026. Following the earnings release, management will host a conference call and simultaneous webcast. The conference call will begin at 5 p.m. Eastern (3 p.m. Mountain) and will be accessible by dialing 877-407-5783 (or +1-201-689-8782 for international callers). Investors are invited to listen to the webcast live via the Internet at:   https://event.choruscall.com/mediaframe/webcast.html?webcastid=bHcTbFnv The webcast also will be available on the Investor page of DMC's website, located at: ir.dm

    4/24/26 7:00:00 AM ET
    $BOOM
    Industrial Specialties
    Industrials

    Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH

    SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option Income Strategy ETFs: IMST, ICOI, IMRA, IGME, ICRC, and IETH. FundTickerDistribution Per ShareDistribution Rate30-Day SEC YieldReturn of CapitalEx-Date / Record DatePayment Date1-Month Return1-Year ReturnSince InceptionReturn*Bitwise COINOption Income Strategy ETFICOI$0.2544725.40 %0.00 %100.00 %4/24/20264/28/2026-4.73 %-28.24 %-24.19 %Bitwise MARAOption Income Strategy ETFIMRA$0.1476311.25 %0.00 %100.00 %4/24/2

    4/23/26 5:06:00 PM ET
    $IMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care